Core Insights - Peninsula Medical's product ZenTite has been installed at the Wellman Center for Photomedicine in Boston, marking a significant step in the company's global strategy and showcasing the international presence of Chinese medical aesthetic brands [1][2] - The Wellman Center, affiliated with Harvard Medical School, is a leading institution in photomedicine research and clinical applications, enhancing the credibility of the installation [1] - Dr. R. Rox Anderson, a prominent figure in laser science and medicine, led the installation, highlighting the product's acceptance by influential experts in the field [1][3] Company Developments - Since obtaining FDA 510(k) registration for its Golden Microneedle in early 2023, Peninsula Medical has accelerated the deployment of its major equipment in six renowned hospitals in the U.S., including five installations of ZenTite [2] - The company has also successfully installed its ultrasound device at the Beckman Laser Institute & Medical Clinic, marking its first entry into the U.S. market with this product [2][3] Industry Position - Peninsula Medical is recognized as a leading brand in the global photomedicine and aesthetic device market, with a strong emphasis on collaboration with clinical experts to drive product development [3][4] - The company has a significant R&D workforce, with nearly 400 researchers, representing 30% of its total employees, and holds an 80% market share in the domestic ultrasound aesthetic sector [4]